Traders should monitor for announcements regarding a reverse stock split or other compliance measures by October 2026; absence of action may precede delisting risk and downward price pressure.
Price Chart
Executive Summary
Genenta Science received a Nasdaq deficiency letter due to its stock trading below $1 for 30 consecutive days, triggering a 180-day compliance period to regain listing eligibility. The company has until October 7, 2026, to restore compliance, potentially via a reverse stock split.
Key Facts
- Received Nasdaq deficiency letter on April 10, 2026, for failing to maintain a minimum $1 bid price.
- Stock has traded below $1 since February 26, 2026.
- 180-day compliance period granted, expiring October 7, 2026.
- Potential reverse stock split under evaluation to regain compliance.
- No immediate delisting, but failure to comply could lead to delisting proceedings.
Financial Impact
High risk of delisting if compliance not achieved; potential reverse stock split would dilute shareholders and signal financial distress.
Risk Factors
- Failure to regain compliance could result in delisting from Nasdaq.
- Reverse stock split may lead to further investor skepticism and selling pressure.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-016540 |
| Document: 0001493152-26-016540-index-headers.html | 0001493152-26-016540 |
| Document: 0001493152-26-016540-index.html | 0001493152-26-016540 |
| Document: 0001493152-26-016540.txt | 0001493152-26-016540 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 6-K | $0.6300 | awaiting T+60 | — | $0.6239 (−0.97%) |
Oct 21, 2026 5d ago | 6-K | $0.6301 | awaiting T+60 | — | $0.6239 (+0.98%) |
Oct 21, 2026 5d ago | Press Release | $0.6301 | awaiting T+60 | — | $0.6239 (+0.98%) |
Oct 13, 2026 13d ago | 6-K | $0.6602 | awaiting T+60 | — | $0.6239 (+5.50%) |
Oct 7, 2026 19d ago | 6-K | $0.7101 | awaiting T+60 | — | $0.6239 (−12.14%) |
Oct 2, 2026 24d ago | SC 13D/A | $0.7450 | awaiting T+60 | — | $0.6239 (−16.26%) |
Jul 22, 2026 13w ago | Press Release | $1.64 $0.6694 | ▼ −59.18% | ▼ −62.44% | $0.6239 (−61.96%) |
Jun 26, 2026 17w ago | 6-K | $1.80 $0.7040 | ▼ −60.89% | ▼ −65.27% | $0.6239 (−65.34%) |
Jun 17, 2026 18w ago | 6-K | $1.84 $0.8408 | ▼ −54.30% | ▼ −57.45% | $0.6239 (−66.09%) |
Jun 16, 2026 19w ago | 6-K | $1.87 $0.8613 | ▼ −53.94% | ▼ −54.94% | $0.6239 (−66.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers